SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5cpr'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DF7_A_MTXA501_1 (DIHYDROFOLATE REDUCTASE)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	5 / 12	ILE B 212 ALA B 214 ILE B 297 VAL B 282 ILE B 271	None	0.98A	1df7A-5cprB: undetectable	1df7A-5cprB: 16.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DIT_P_2PPP1_1 (ALPHA-THROMBIN PEPTIDE INHIBITOR CVS995)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	4 / 6	LEU B 294 ILE B 297 ASP B 274 PRO B 277	None	1.23A	1ditH-5cprB: undetectable 1ditP-5cprB: undetectable	1ditH-5cprB: 22.53 1ditP-5cprB: 5.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E3V_A_DXCA801_0 (STEROID DELTA-ISOMERASE)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	5 / 12	TYR B 307 PHE B 281 VAL B 291 LEU B 227 ALA B 269	539 B 403 ( 3.9A) 539 B 403 (-3.5A) None None 539 B 403 ( 4.0A)	1.48A	1e3vA-5cprB: undetectable	1e3vA-5cprB: 17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EA1_A_TPFA470_1 (CYTOCHROME P450 51-LIKE RV0764C)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	4 / 8	PHE B 189 MET B 188 THR B 97 LEU B 93	None	0.91A	1ea1A-5cprB: 2.2	1ea1A-5cprB: 20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H21_A_SAMA801_0 (RIBULOSE-1,5 BISPHOSPHATE CARBOXYLASE/OXYGENAS E)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	5 / 10	SER B 251 ASN B 272 HIS B 273 TYR B 307 PHE B 312	SAM B 402 (-3.9A) SAM B 402 (-3.1A) SAM B 402 (-4.5A) 539 B 403 ( 3.9A) SAM B 402 (-3.7A)	1.33A	2h21A-5cprB: 6.4	2h21A-5cprB: 21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H21_B_SAMB802_0 (RIBULOSE-1,5 BISPHOSPHATE CARBOXYLASE/OXYGENAS E)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	5 / 11	SER B 251 ASN B 272 HIS B 273 TYR B 307 PHE B 312	SAM B 402 (-3.9A) SAM B 402 (-3.1A) SAM B 402 (-4.5A) 539 B 403 ( 3.9A) SAM B 402 (-3.7A)	1.33A	2h21B-5cprB: 5.7	2h21B-5cprB: 21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H21_C_SAMC803_0 (RIBULOSE-1,5 BISPHOSPHATE CARBOXYLASE/OXYGENAS E)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	5 / 11	SER B 251 ASN B 272 HIS B 273 TYR B 307 PHE B 312	SAM B 402 (-3.9A) SAM B 402 (-3.1A) SAM B 402 (-4.5A) 539 B 403 ( 3.9A) SAM B 402 (-3.7A)	1.32A	2h21C-5cprB: 5.9	2h21C-5cprB: 21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HBB_B_TMQB612_1 (DIHYDROFOLATE REDUCTASE-THYMIDYLAT E SYNTHASE)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	5 / 9	ALA B 268 ILE B 184 THR B 85 PHE B 144 ILE B 197	539 B 403 (-3.6A) None None None None	1.43A	3hbbB-5cprB: undetectable	3hbbB-5cprB: 20.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OOI_A_SAMA237_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-36 AND H4 LYSINE-20 SPECIFIC)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	5 / 12	ASN B 272 HIS B 273 TYR B 307 CYH B 319 CYH B 321	SAM B 402 (-3.1A) SAM B 402 (-4.5A) 539 B 403 ( 3.9A) ZN B 401 ( 2.3A) ZN B 401 ( 2.2A)	0.39A	3ooiA-5cprB: 7.7	3ooiA-5cprB: 24.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RQ4_A_SAMA500_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H2)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	5 / 12	GLY B 246 SER B 251 HIS B 273 TYR B 307 CYH B 319	None SAM B 402 (-3.9A) SAM B 402 (-4.5A) 539 B 403 ( 3.9A) ZN B 401 ( 2.3A)	1.43A	3rq4A-5cprB: 33.6	3rq4A-5cprB: 58.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RQ4_A_SAMA500_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H2)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	11 / 12	TYR B 203 GLU B 206 GLY B 209 SER B 251 ASN B 272 HIS B 273 TYR B 307 PHE B 312 CYH B 319 GLU B 320 CYH B 321	SAM B 402 (-3.7A) SAM B 402 (-2.9A) SAM B 402 (-3.4A) SAM B 402 (-3.9A) SAM B 402 (-3.1A) SAM B 402 (-4.5A) 539 B 403 ( 3.9A) SAM B 402 (-3.7A) ZN B 401 ( 2.3A) SAM B 402 (-4.6A) ZN B 401 ( 2.2A)	0.19A	3rq4A-5cprB: 33.6	3rq4A-5cprB: 58.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RQ4_A_SAMA500_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H2)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	8 / 12	TYR B 203 GLU B 206 GLY B 209 SER B 251 HIS B 273 TYR B 307 CYH B 321 GLU B 320	SAM B 402 (-3.7A) SAM B 402 (-2.9A) SAM B 402 (-3.4A) SAM B 402 (-3.9A) SAM B 402 (-4.5A) 539 B 403 ( 3.9A) ZN B 401 ( 2.2A) SAM B 402 (-4.6A)	1.42A	3rq4A-5cprB: 33.6	3rq4A-5cprB: 58.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3S8P_A_SAMA500_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	11 / 12	TYR B 203 GLY B 209 ALA B 210 PHE B 250 ASN B 272 HIS B 273 TYR B 307 PHE B 312 CYH B 319 GLU B 320 CYH B 321	SAM B 402 (-3.7A) SAM B 402 (-3.4A) SAM B 402 (-3.9A) None SAM B 402 (-3.1A) SAM B 402 (-4.5A) 539 B 403 ( 3.9A) SAM B 402 (-3.7A) ZN B 401 ( 2.3A) SAM B 402 (-4.6A) ZN B 401 ( 2.2A)	0.25A	3s8pA-5cprB: 38.0	3s8pA-5cprB: 97.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3S8P_A_SAMA500_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	11 / 12	TYR B 203 GLY B 209 ALA B 210 SER B 251 ASN B 272 HIS B 273 TYR B 307 PHE B 312 CYH B 319 GLU B 320 CYH B 321	SAM B 402 (-3.7A) SAM B 402 (-3.4A) SAM B 402 (-3.9A) SAM B 402 (-3.9A) SAM B 402 (-3.1A) SAM B 402 (-4.5A) 539 B 403 ( 3.9A) SAM B 402 (-3.7A) ZN B 401 ( 2.3A) SAM B 402 (-4.6A) ZN B 401 ( 2.2A)	0.46A	3s8pA-5cprB: 38.0	3s8pA-5cprB: 97.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3S8P_A_SAMA500_1 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	3 / 3	HIS B 98 SER B 205 GLU B 206	SAM B 402 (-3.7A) SAM B 402 (-2.7A) SAM B 402 (-2.9A)	0.19A	3s8pA-5cprB: 38.0	3s8pA-5cprB: 97.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3S8P_B_SAMB500_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	11 / 12	TYR B 203 GLU B 206 GLY B 209 ALA B 210 PHE B 250 HIS B 273 TYR B 307 PHE B 312 CYH B 319 GLU B 320 CYH B 321	SAM B 402 (-3.7A) SAM B 402 (-2.9A) SAM B 402 (-3.4A) SAM B 402 (-3.9A) None SAM B 402 (-4.5A) 539 B 403 ( 3.9A) SAM B 402 (-3.7A) ZN B 401 ( 2.3A) SAM B 402 (-4.6A) ZN B 401 ( 2.2A)	0.26A	3s8pB-5cprB: 35.7	3s8pB-5cprB: 97.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3S8P_B_SAMB500_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	11 / 12	TYR B 203 GLU B 206 GLY B 209 ALA B 210 SER B 251 HIS B 273 TYR B 307 PHE B 312 CYH B 319 GLU B 320 CYH B 321	SAM B 402 (-3.7A) SAM B 402 (-2.9A) SAM B 402 (-3.4A) SAM B 402 (-3.9A) SAM B 402 (-3.9A) SAM B 402 (-4.5A) 539 B 403 ( 3.9A) SAM B 402 (-3.7A) ZN B 401 ( 2.3A) SAM B 402 (-4.6A) ZN B 401 ( 2.2A)	0.46A	3s8pB-5cprB: 35.7	3s8pB-5cprB: 97.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3S8P_B_SAMB500_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	8 / 12	TYR B 203 GLU B 206 GLY B 209 PHE B 250 HIS B 273 TYR B 307 GLU B 320 CYH B 319	SAM B 402 (-3.7A) SAM B 402 (-2.9A) SAM B 402 (-3.4A) None SAM B 402 (-4.5A) 539 B 403 ( 3.9A) SAM B 402 (-4.6A) ZN B 401 ( 2.3A)	1.41A	3s8pB-5cprB: 35.7	3s8pB-5cprB: 97.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3S8P_B_SAMB500_1 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	3 / 3	HIS B 98 SER B 205 ASN B 272	SAM B 402 (-3.7A) SAM B 402 (-2.7A) SAM B 402 (-3.1A)	0.16A	3s8pB-5cprB: 35.7	3s8pB-5cprB: 97.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BUP_A_SAMA500_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	12 / 12	TYR B 203 GLU B 206 GLY B 209 ALA B 210 SER B 251 ASN B 272 HIS B 273 TYR B 307 PHE B 312 CYH B 319 GLU B 320 CYH B 321	SAM B 402 (-3.7A) SAM B 402 (-2.9A) SAM B 402 (-3.4A) SAM B 402 (-3.9A) SAM B 402 (-3.9A) SAM B 402 (-3.1A) SAM B 402 (-4.5A) 539 B 403 ( 3.9A) SAM B 402 (-3.7A) ZN B 401 ( 2.3A) SAM B 402 (-4.6A) ZN B 401 ( 2.2A)	0.49A	4bupA-5cprB: 36.0	4bupA-5cprB: 98.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BUP_B_SAMB500_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	7 / 12	TYR B 203 GLY B 209 PHE B 250 HIS B 273 TYR B 307 GLU B 320 CYH B 319	SAM B 402 (-3.7A) SAM B 402 (-3.4A) None SAM B 402 (-4.5A) 539 B 403 ( 3.9A) SAM B 402 (-4.6A) ZN B 401 ( 2.3A)	1.48A	4bupB-5cprB: 37.4	4bupB-5cprB: 98.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BUP_B_SAMB500_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	5 / 12	TYR B 203 SER B 204 HIS B 273 CYH B 319 CYH B 321	SAM B 402 (-3.7A) None SAM B 402 (-4.5A) ZN B 401 ( 2.3A) ZN B 401 ( 2.2A)	1.14A	4bupB-5cprB: 37.4	4bupB-5cprB: 98.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BUP_B_SAMB500_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	11 / 12	TYR B 203 SER B 205 GLY B 209 ALA B 210 PHE B 250 HIS B 273 TYR B 307 PHE B 312 CYH B 319 GLU B 320 CYH B 321	SAM B 402 (-3.7A) SAM B 402 (-2.7A) SAM B 402 (-3.4A) SAM B 402 (-3.9A) None SAM B 402 (-4.5A) 539 B 403 ( 3.9A) SAM B 402 (-3.7A) ZN B 401 ( 2.3A) SAM B 402 (-4.6A) ZN B 401 ( 2.2A)	0.31A	4bupB-5cprB: 37.4	4bupB-5cprB: 98.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BUP_B_SAMB500_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	11 / 12	TYR B 203 SER B 205 GLY B 209 ALA B 210 SER B 251 HIS B 273 TYR B 307 PHE B 312 CYH B 319 GLU B 320 CYH B 321	SAM B 402 (-3.7A) SAM B 402 (-2.7A) SAM B 402 (-3.4A) SAM B 402 (-3.9A) SAM B 402 (-3.9A) SAM B 402 (-4.5A) 539 B 403 ( 3.9A) SAM B 402 (-3.7A) ZN B 401 ( 2.3A) SAM B 402 (-4.6A) ZN B 401 ( 2.2A)	0.51A	4bupB-5cprB: 37.4	4bupB-5cprB: 98.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BUP_B_SAMB500_1 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	3 / 3	HIS B 98 GLU B 206 ASN B 272	SAM B 402 (-3.7A) SAM B 402 (-2.9A) SAM B 402 (-3.1A)	0.14A	4bupB-5cprB: 37.4	4bupB-5cprB: 98.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RS0_A_IBPA706_1 (PROSTAGLANDIN G/H SYNTHASE 2)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	5 / 9	VAL B 252 SER B 251 LEU B 263 GLY B 246 LEU B 243	None SAM B 402 (-3.9A) None None None	1.05A	4rs0A-5cprB: undetectable	4rs0A-5cprB: 18.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CPR_B_SAMB402_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	12 / 12	TYR B 203 GLU B 206 GLY B 209 ALA B 210 PHE B 250 SER B 251 HIS B 273 TYR B 307 PHE B 312 CYH B 319 GLU B 320 CYH B 321	SAM B 402 (-3.7A) SAM B 402 (-2.9A) SAM B 402 (-3.4A) SAM B 402 (-3.9A) None SAM B 402 (-3.9A) SAM B 402 (-4.5A) 539 B 403 ( 3.9A) SAM B 402 (-3.7A) ZN B 401 ( 2.3A) SAM B 402 (-4.6A) ZN B 401 ( 2.2A)	0.01A	5cprB-5cprB: 41.8	5cprB-5cprB: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CPR_B_SAMB402_1 (HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	3 / 3	HIS B 98 SER B 205 ASN B 272	SAM B 402 (-3.7A) SAM B 402 (-2.7A) SAM B 402 (-3.1A)	0.01A	5cprB-5cprB: 41.8	5cprB-5cprB: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LSU_B_SAMB1304_1 (HISTONE-LYSINE N-METHYLTRANSFERASE NSD2)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	3 / 3	ASN B 272 TYR B 307 CYH B 319	SAM B 402 (-3.1A) 539 B 403 ( 3.9A) ZN B 401 ( 2.3A)	0.43A	5lsuB-5cprB: 7.3	5lsuB-5cprB: 24.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UPD_A_SAMA1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE NSD3)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	5 / 11	ASN B 272 HIS B 273 TYR B 307 CYH B 319 CYH B 321	SAM B 402 (-3.1A) SAM B 402 (-4.5A) 539 B 403 ( 3.9A) ZN B 401 ( 2.3A) ZN B 401 ( 2.2A)	0.53A	5updA-5cprB: 7.4	5updA-5cprB: 24.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5WBV_A_SAMA402_0 (HISTONE-LYSINE N-METHYLTRANSFERASE KMT5B)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	6 / 12	TYR B 203 SER B 204 GLY B 209 CYH B 319 GLU B 320 CYH B 321	SAM B 402 (-3.7A) None SAM B 402 (-3.4A) ZN B 401 ( 2.3A) SAM B 402 (-4.6A) ZN B 401 ( 2.2A)	1.17A	5wbvA-5cprB: 37.6	5wbvA-5cprB: 97.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5WBV_A_SAMA402_0 (HISTONE-LYSINE N-METHYLTRANSFERASE KMT5B)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	11 / 12	TYR B 203 SER B 205 GLY B 209 ALA B 210 PHE B 250 HIS B 273 TYR B 307 PHE B 312 CYH B 319 GLU B 320 CYH B 321	SAM B 402 (-3.7A) SAM B 402 (-2.7A) SAM B 402 (-3.4A) SAM B 402 (-3.9A) None SAM B 402 (-4.5A) 539 B 403 ( 3.9A) SAM B 402 (-3.7A) ZN B 401 ( 2.3A) SAM B 402 (-4.6A) ZN B 401 ( 2.2A)	0.49A	5wbvA-5cprB: 37.6	5wbvA-5cprB: 97.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5WBV_A_SAMA402_0 (HISTONE-LYSINE N-METHYLTRANSFERASE KMT5B)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	11 / 12	TYR B 203 SER B 205 GLY B 209 ALA B 210 SER B 251 HIS B 273 TYR B 307 PHE B 312 CYH B 319 GLU B 320 CYH B 321	SAM B 402 (-3.7A) SAM B 402 (-2.7A) SAM B 402 (-3.4A) SAM B 402 (-3.9A) SAM B 402 (-3.9A) SAM B 402 (-4.5A) 539 B 403 ( 3.9A) SAM B 402 (-3.7A) ZN B 401 ( 2.3A) SAM B 402 (-4.6A) ZN B 401 ( 2.2A)	0.60A	5wbvA-5cprB: 37.6	5wbvA-5cprB: 97.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5WBV_A_SAMA402_1 (HISTONE-LYSINE N-METHYLTRANSFERASE KMT5B)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	3 / 3	HIS B 98 GLU B 206 ASN B 272	SAM B 402 (-3.7A) SAM B 402 (-2.9A) SAM B 402 (-3.1A)	0.22A	5wbvA-5cprB: 37.6	5wbvA-5cprB: 97.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5WBV_B_SAMB402_0 (HISTONE-LYSINE N-METHYLTRANSFERASE KMT5B)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	6 / 12	TYR B 203 SER B 204 GLY B 209 CYH B 319 GLU B 320 CYH B 321	SAM B 402 (-3.7A) None SAM B 402 (-3.4A) ZN B 401 ( 2.3A) SAM B 402 (-4.6A) ZN B 401 ( 2.2A)	1.15A	5wbvB-5cprB: 35.5	5wbvB-5cprB: 97.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5WBV_B_SAMB402_0 (HISTONE-LYSINE N-METHYLTRANSFERASE KMT5B)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	11 / 12	TYR B 203 SER B 205 GLY B 209 ALA B 210 PHE B 250 HIS B 273 TYR B 307 PHE B 312 CYH B 319 GLU B 320 CYH B 321	SAM B 402 (-3.7A) SAM B 402 (-2.7A) SAM B 402 (-3.4A) SAM B 402 (-3.9A) None SAM B 402 (-4.5A) 539 B 403 ( 3.9A) SAM B 402 (-3.7A) ZN B 401 ( 2.3A) SAM B 402 (-4.6A) ZN B 401 ( 2.2A)	0.48A	5wbvB-5cprB: 35.5	5wbvB-5cprB: 97.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5WBV_B_SAMB402_0 (HISTONE-LYSINE N-METHYLTRANSFERASE KMT5B)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	11 / 12	TYR B 203 SER B 205 GLY B 209 ALA B 210 SER B 251 HIS B 273 TYR B 307 PHE B 312 CYH B 319 GLU B 320 CYH B 321	SAM B 402 (-3.7A) SAM B 402 (-2.7A) SAM B 402 (-3.4A) SAM B 402 (-3.9A) SAM B 402 (-3.9A) SAM B 402 (-4.5A) 539 B 403 ( 3.9A) SAM B 402 (-3.7A) ZN B 401 ( 2.3A) SAM B 402 (-4.6A) ZN B 401 ( 2.2A)	0.59A	5wbvB-5cprB: 35.5	5wbvB-5cprB: 97.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5WBV_B_SAMB402_1 (HISTONE-LYSINE N-METHYLTRANSFERASE KMT5B)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	3 / 3	HIS B 98 GLU B 206 ASN B 272	SAM B 402 (-3.7A) SAM B 402 (-2.9A) SAM B 402 (-3.1A)	0.22A	5wbvB-5cprB: 35.5	5wbvB-5cprB: 97.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A5K_A_SAMA805_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC SUVH6)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	5 / 12	ASN B 272 HIS B 273 TYR B 307 CYH B 319 CYH B 321	SAM B 402 (-3.1A) SAM B 402 (-4.5A) 539 B 403 ( 3.9A) ZN B 401 ( 2.3A) ZN B 401 ( 2.2A)	0.42A	6a5kA-5cprB: 8.3	6a5kA-5cprB: 21.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6A5M_A_SAMA805_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC SUVH6)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	5 / 12	ASN B 272 HIS B 273 TYR B 307 CYH B 319 CYH B 321	SAM B 402 (-3.1A) SAM B 402 (-4.5A) 539 B 403 ( 3.9A) ZN B 401 ( 2.3A) ZN B 401 ( 2.2A)	0.38A	6a5mA-5cprB: undetectable	6a5mA-5cprB: 21.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6AGO_A_SAMA2301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	5 / 11	ASN B 272 HIS B 273 TYR B 307 CYH B 319 CYH B 321	SAM B 402 (-3.1A) SAM B 402 (-4.5A) 539 B 403 ( 3.9A) ZN B 401 ( 2.3A) ZN B 401 ( 2.2A)	0.87A	6agoA-5cprB: 7.8	6agoA-5cprB: 26.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CEN_A_SAMA1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE NSD3)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	5 / 11	ASN B 272 HIS B 273 TYR B 307 CYH B 319 CYH B 321	SAM B 402 (-3.1A) SAM B 402 (-4.5A) 539 B 403 ( 3.9A) ZN B 401 ( 2.3A) ZN B 401 ( 2.2A)	0.53A	6cenA-5cprB: 7.4	6cenA-5cprB: 23.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6INE_A_SAMA2304_0 (HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L)	5cpr	HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1 (Homo sapiens)	5 / 12	ASN B 272 HIS B 273 TYR B 307 CYH B 319 CYH B 321	SAM B 402 (-3.1A) SAM B 402 (-4.5A) 539 B 403 ( 3.9A) ZN B 401 ( 2.3A) ZN B 401 ( 2.2A)	0.49A	6ineA-5cprB: 7.5	6ineA-5cprB: 25.33

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1DF7_A_MTXA501_1","DIHYDROFOLATE REDUCTASE","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",5,"ILE B 212;ALA B 214;ILE B 297;VAL B 282;ILE B 271","None","0.98A","1df7A-5cprB:undetectable","1df7A-5cprB:16.18"],["1DIT_P_2PPP1_1","ALPHA-THROMBIN;PEPTIDE INHIBITOR CVS995","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",4,"LEU B 294;ILE B 297;ASP B 274;PRO B 277","None","1.23A","1ditH-5cprB:undetectable;1ditP-5cprB:undetectable","1ditH-5cprB:22.53;1ditP-5cprB:5.83"],["1E3V_A_DXCA801_0","STEROID DELTA-ISOMERASE","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",5,"TYR B 307;PHE B 281;VAL B 291;LEU B 227;ALA B 269","539 B 403 ( 3.9A);539 B 403 (-3.5A);None;None;539 B 403 ( 4.0A)","1.48A","1e3vA-5cprB:undetectable","1e3vA-5cprB:17.09"],["1EA1_A_TPFA470_1","CYTOCHROME P450 51-LIKE RV0764C","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",4,"PHE B 189;MET B 188;THR B  97;LEU B  93","None","0.91A","1ea1A-5cprB:2.2","1ea1A-5cprB:20.22"],["2H21_A_SAMA801_0","RIBULOSE-1,5 BISPHOSPHATE CARBOXYLASE\/OXYGENASE","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",5,"SER B 251;ASN B 272;HIS B 273;TYR B 307;PHE B 312","SAM B 402 (-3.9A);SAM B 402 (-3.1A);SAM B 402 (-4.5A);539 B 403 ( 3.9A);SAM B 402 (-3.7A)","1.33A","2h21A-5cprB:6.4","2h21A-5cprB:21.35"],["2H21_B_SAMB802_0","RIBULOSE-1,5 BISPHOSPHATE CARBOXYLASE\/OXYGENASE","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",5,"SER B 251;ASN B 272;HIS B 273;TYR B 307;PHE B 312","SAM B 402 (-3.9A);SAM B 402 (-3.1A);SAM B 402 (-4.5A);539 B 403 ( 3.9A);SAM B 402 (-3.7A)","1.33A","2h21B-5cprB:5.7","2h21B-5cprB:21.35"],["2H21_C_SAMC803_0","RIBULOSE-1,5 BISPHOSPHATE CARBOXYLASE\/OXYGENASE","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",5,"SER B 251;ASN B 272;HIS B 273;TYR B 307;PHE B 312","SAM B 402 (-3.9A);SAM B 402 (-3.1A);SAM B 402 (-4.5A);539 B 403 ( 3.9A);SAM B 402 (-3.7A)","1.32A","2h21C-5cprB:5.9","2h21C-5cprB:21.35"],["3HBB_B_TMQB612_1","DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",5,"ALA B 268;ILE B 184;THR B  85;PHE B 144;ILE B 197","539 B 403 (-3.6A);None;None;None;None","1.43A","3hbbB-5cprB:undetectable","3hbbB-5cprB:20.61"],["3OOI_A_SAMA237_0","HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-36 AND H4 LYSINE-20 SPECIFIC","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",5,"ASN B 272;HIS B 273;TYR B 307;CYH B 319;CYH B 321","SAM B 402 (-3.1A);SAM B 402 (-4.5A);539 B 403 ( 3.9A); ZN B 401 ( 2.3A); ZN B 401 ( 2.2A)","0.39A","3ooiA-5cprB:7.7","3ooiA-5cprB:24.91"],["3RQ4_A_SAMA500_0","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H2","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",5,"GLY B 246;SER B 251;HIS B 273;TYR B 307;CYH B 319","None;SAM B 402 (-3.9A);SAM B 402 (-4.5A);539 B 403 ( 3.9A); ZN B 401 ( 2.3A)","1.43A","3rq4A-5cprB:33.6","3rq4A-5cprB:58.96"],["3RQ4_A_SAMA500_0","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H2","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",11,"TYR B 203;GLU B 206;GLY B 209;SER B 251;ASN B 272;HIS B 273;TYR B 307;PHE B 312;CYH B 319;GLU B 320;CYH B 321","SAM B 402 (-3.7A);SAM B 402 (-2.9A);SAM B 402 (-3.4A);SAM B 402 (-3.9A);SAM B 402 (-3.1A);SAM B 402 (-4.5A);539 B 403 ( 3.9A);SAM B 402 (-3.7A); ZN B 401 ( 2.3A);SAM B 402 (-4.6A); ZN B 401 ( 2.2A)","0.19A","3rq4A-5cprB:33.6","3rq4A-5cprB:58.96"],["3RQ4_A_SAMA500_0","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H2","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",8,"TYR B 203;GLU B 206;GLY B 209;SER B 251;HIS B 273;TYR B 307;CYH B 321;GLU B 320","SAM B 402 (-3.7A);SAM B 402 (-2.9A);SAM B 402 (-3.4A);SAM B 402 (-3.9A);SAM B 402 (-4.5A);539 B 403 ( 3.9A); ZN B 401 ( 2.2A);SAM B 402 (-4.6A)","1.42A","3rq4A-5cprB:33.6","3rq4A-5cprB:58.96"],["3S8P_A_SAMA500_0","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",11,"TYR B 203;GLY B 209;ALA B 210;PHE B 250;ASN B 272;HIS B 273;TYR B 307;PHE B 312;CYH B 319;GLU B 320;CYH B 321","SAM B 402 (-3.7A);SAM B 402 (-3.4A);SAM B 402 (-3.9A);None;SAM B 402 (-3.1A);SAM B 402 (-4.5A);539 B 403 ( 3.9A);SAM B 402 (-3.7A); ZN B 401 ( 2.3A);SAM B 402 (-4.6A); ZN B 401 ( 2.2A)","0.25A","3s8pA-5cprB:38.0","3s8pA-5cprB:97.80"],["3S8P_A_SAMA500_0","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",11,"TYR B 203;GLY B 209;ALA B 210;SER B 251;ASN B 272;HIS B 273;TYR B 307;PHE B 312;CYH B 319;GLU B 320;CYH B 321","SAM B 402 (-3.7A);SAM B 402 (-3.4A);SAM B 402 (-3.9A);SAM B 402 (-3.9A);SAM B 402 (-3.1A);SAM B 402 (-4.5A);539 B 403 ( 3.9A);SAM B 402 (-3.7A); ZN B 401 ( 2.3A);SAM B 402 (-4.6A); ZN B 401 ( 2.2A)","0.46A","3s8pA-5cprB:38.0","3s8pA-5cprB:97.80"],["3S8P_A_SAMA500_1","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",3,"HIS B  98;SER B 205;GLU B 206","SAM B 402 (-3.7A);SAM B 402 (-2.7A);SAM B 402 (-2.9A)","0.19A","3s8pA-5cprB:38.0","3s8pA-5cprB:97.80"],["3S8P_B_SAMB500_0","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",11,"TYR B 203;GLU B 206;GLY B 209;ALA B 210;PHE B 250;HIS B 273;TYR B 307;PHE B 312;CYH B 319;GLU B 320;CYH B 321","SAM B 402 (-3.7A);SAM B 402 (-2.9A);SAM B 402 (-3.4A);SAM B 402 (-3.9A);None;SAM B 402 (-4.5A);539 B 403 ( 3.9A);SAM B 402 (-3.7A); ZN B 401 ( 2.3A);SAM B 402 (-4.6A); ZN B 401 ( 2.2A)","0.26A","3s8pB-5cprB:35.7","3s8pB-5cprB:97.80"],["3S8P_B_SAMB500_0","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",11,"TYR B 203;GLU B 206;GLY B 209;ALA B 210;SER B 251;HIS B 273;TYR B 307;PHE B 312;CYH B 319;GLU B 320;CYH B 321","SAM B 402 (-3.7A);SAM B 402 (-2.9A);SAM B 402 (-3.4A);SAM B 402 (-3.9A);SAM B 402 (-3.9A);SAM B 402 (-4.5A);539 B 403 ( 3.9A);SAM B 402 (-3.7A); ZN B 401 ( 2.3A);SAM B 402 (-4.6A); ZN B 401 ( 2.2A)","0.46A","3s8pB-5cprB:35.7","3s8pB-5cprB:97.80"],["3S8P_B_SAMB500_0","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",8,"TYR B 203;GLU B 206;GLY B 209;PHE B 250;HIS B 273;TYR B 307;GLU B 320;CYH B 319","SAM B 402 (-3.7A);SAM B 402 (-2.9A);SAM B 402 (-3.4A);None;SAM B 402 (-4.5A);539 B 403 ( 3.9A);SAM B 402 (-4.6A); ZN B 401 ( 2.3A)","1.41A","3s8pB-5cprB:35.7","3s8pB-5cprB:97.80"],["3S8P_B_SAMB500_1","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",3,"HIS B  98;SER B 205;ASN B 272","SAM B 402 (-3.7A);SAM B 402 (-2.7A);SAM B 402 (-3.1A)","0.16A","3s8pB-5cprB:35.7","3s8pB-5cprB:97.80"],["4BUP_A_SAMA500_0","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",12,"TYR B 203;GLU B 206;GLY B 209;ALA B 210;SER B 251;ASN B 272;HIS B 273;TYR B 307;PHE B 312;CYH B 319;GLU B 320;CYH B 321","SAM B 402 (-3.7A);SAM B 402 (-2.9A);SAM B 402 (-3.4A);SAM B 402 (-3.9A);SAM B 402 (-3.9A);SAM B 402 (-3.1A);SAM B 402 (-4.5A);539 B 403 ( 3.9A);SAM B 402 (-3.7A); ZN B 401 ( 2.3A);SAM B 402 (-4.6A); ZN B 401 ( 2.2A)","0.49A","4bupA-5cprB:36.0","4bupA-5cprB:98.15"],["4BUP_B_SAMB500_0","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",7,"TYR B 203;GLY B 209;PHE B 250;HIS B 273;TYR B 307;GLU B 320;CYH B 319","SAM B 402 (-3.7A);SAM B 402 (-3.4A);None;SAM B 402 (-4.5A);539 B 403 ( 3.9A);SAM B 402 (-4.6A); ZN B 401 ( 2.3A)","1.48A","4bupB-5cprB:37.4","4bupB-5cprB:98.15"],["4BUP_B_SAMB500_0","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",5,"TYR B 203;SER B 204;HIS B 273;CYH B 319;CYH B 321","SAM B 402 (-3.7A);None;SAM B 402 (-4.5A); ZN B 401 ( 2.3A); ZN B 401 ( 2.2A)","1.14A","4bupB-5cprB:37.4","4bupB-5cprB:98.15"],["4BUP_B_SAMB500_0","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",11,"TYR B 203;SER B 205;GLY B 209;ALA B 210;PHE B 250;HIS B 273;TYR B 307;PHE B 312;CYH B 319;GLU B 320;CYH B 321","SAM B 402 (-3.7A);SAM B 402 (-2.7A);SAM B 402 (-3.4A);SAM B 402 (-3.9A);None;SAM B 402 (-4.5A);539 B 403 ( 3.9A);SAM B 402 (-3.7A); ZN B 401 ( 2.3A);SAM B 402 (-4.6A); ZN B 401 ( 2.2A)","0.31A","4bupB-5cprB:37.4","4bupB-5cprB:98.15"],["4BUP_B_SAMB500_0","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",11,"TYR B 203;SER B 205;GLY B 209;ALA B 210;SER B 251;HIS B 273;TYR B 307;PHE B 312;CYH B 319;GLU B 320;CYH B 321","SAM B 402 (-3.7A);SAM B 402 (-2.7A);SAM B 402 (-3.4A);SAM B 402 (-3.9A);SAM B 402 (-3.9A);SAM B 402 (-4.5A);539 B 403 ( 3.9A);SAM B 402 (-3.7A); ZN B 401 ( 2.3A);SAM B 402 (-4.6A); ZN B 401 ( 2.2A)","0.51A","4bupB-5cprB:37.4","4bupB-5cprB:98.15"],["4BUP_B_SAMB500_1","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",3,"HIS B  98;GLU B 206;ASN B 272","SAM B 402 (-3.7A);SAM B 402 (-2.9A);SAM B 402 (-3.1A)","0.14A","4bupB-5cprB:37.4","4bupB-5cprB:98.15"],["4RS0_A_IBPA706_1","PROSTAGLANDIN G\/H SYNTHASE 2","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",5,"VAL B 252;SER B 251;LEU B 263;GLY B 246;LEU B 243","None;SAM B 402 (-3.9A);None;None;None","1.05A","4rs0A-5cprB:undetectable","4rs0A-5cprB:18.71"],["5CPR_B_SAMB402_0","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",12,"TYR B 203;GLU B 206;GLY B 209;ALA B 210;PHE B 250;SER B 251;HIS B 273;TYR B 307;PHE B 312;CYH B 319;GLU B 320;CYH B 321","SAM B 402 (-3.7A);SAM B 402 (-2.9A);SAM B 402 (-3.4A);SAM B 402 (-3.9A);None;SAM B 402 (-3.9A);SAM B 402 (-4.5A);539 B 403 ( 3.9A);SAM B 402 (-3.7A); ZN B 401 ( 2.3A);SAM B 402 (-4.6A); ZN B 401 ( 2.2A)","0.01A","5cprB-5cprB:41.8","5cprB-5cprB:100.00"],["5CPR_B_SAMB402_1","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",3,"HIS B  98;SER B 205;ASN B 272","SAM B 402 (-3.7A);SAM B 402 (-2.7A);SAM B 402 (-3.1A)","0.01A","5cprB-5cprB:41.8","5cprB-5cprB:100.00"],["5LSU_B_SAMB1304_1","HISTONE-LYSINE N-METHYLTRANSFERASE NSD2","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",3,"ASN B 272;TYR B 307;CYH B 319","SAM B 402 (-3.1A);539 B 403 ( 3.9A); ZN B 401 ( 2.3A)","0.43A","5lsuB-5cprB:7.3","5lsuB-5cprB:24.48"],["5UPD_A_SAMA1301_0","HISTONE-LYSINE N-METHYLTRANSFERASE NSD3","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",5,"ASN B 272;HIS B 273;TYR B 307;CYH B 319;CYH B 321","SAM B 402 (-3.1A);SAM B 402 (-4.5A);539 B 403 ( 3.9A); ZN B 401 ( 2.3A); ZN B 401 ( 2.2A)","0.53A","5updA-5cprB:7.4","5updA-5cprB:24.47"],["5WBV_A_SAMA402_0","HISTONE-LYSINE N-METHYLTRANSFERASE KMT5B","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",6,"TYR B 203;SER B 204;GLY B 209;CYH B 319;GLU B 320;CYH B 321","SAM B 402 (-3.7A);None;SAM B 402 (-3.4A); ZN B 401 ( 2.3A);SAM B 402 (-4.6A); ZN B 401 ( 2.2A)","1.17A","5wbvA-5cprB:37.6","5wbvA-5cprB:97.80"],["5WBV_A_SAMA402_0","HISTONE-LYSINE N-METHYLTRANSFERASE KMT5B","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",11,"TYR B 203;SER B 205;GLY B 209;ALA B 210;PHE B 250;HIS B 273;TYR B 307;PHE B 312;CYH B 319;GLU B 320;CYH B 321","SAM B 402 (-3.7A);SAM B 402 (-2.7A);SAM B 402 (-3.4A);SAM B 402 (-3.9A);None;SAM B 402 (-4.5A);539 B 403 ( 3.9A);SAM B 402 (-3.7A); ZN B 401 ( 2.3A);SAM B 402 (-4.6A); ZN B 401 ( 2.2A)","0.49A","5wbvA-5cprB:37.6","5wbvA-5cprB:97.80"],["5WBV_A_SAMA402_0","HISTONE-LYSINE N-METHYLTRANSFERASE KMT5B","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",11,"TYR B 203;SER B 205;GLY B 209;ALA B 210;SER B 251;HIS B 273;TYR B 307;PHE B 312;CYH B 319;GLU B 320;CYH B 321","SAM B 402 (-3.7A);SAM B 402 (-2.7A);SAM B 402 (-3.4A);SAM B 402 (-3.9A);SAM B 402 (-3.9A);SAM B 402 (-4.5A);539 B 403 ( 3.9A);SAM B 402 (-3.7A); ZN B 401 ( 2.3A);SAM B 402 (-4.6A); ZN B 401 ( 2.2A)","0.60A","5wbvA-5cprB:37.6","5wbvA-5cprB:97.80"],["5WBV_A_SAMA402_1","HISTONE-LYSINE N-METHYLTRANSFERASE KMT5B","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",3,"HIS B  98;GLU B 206;ASN B 272","SAM B 402 (-3.7A);SAM B 402 (-2.9A);SAM B 402 (-3.1A)","0.22A","5wbvA-5cprB:37.6","5wbvA-5cprB:97.80"],["5WBV_B_SAMB402_0","HISTONE-LYSINE N-METHYLTRANSFERASE KMT5B","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",6,"TYR B 203;SER B 204;GLY B 209;CYH B 319;GLU B 320;CYH B 321","SAM B 402 (-3.7A);None;SAM B 402 (-3.4A); ZN B 401 ( 2.3A);SAM B 402 (-4.6A); ZN B 401 ( 2.2A)","1.15A","5wbvB-5cprB:35.5","5wbvB-5cprB:97.80"],["5WBV_B_SAMB402_0","HISTONE-LYSINE N-METHYLTRANSFERASE KMT5B","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",11,"TYR B 203;SER B 205;GLY B 209;ALA B 210;PHE B 250;HIS B 273;TYR B 307;PHE B 312;CYH B 319;GLU B 320;CYH B 321","SAM B 402 (-3.7A);SAM B 402 (-2.7A);SAM B 402 (-3.4A);SAM B 402 (-3.9A);None;SAM B 402 (-4.5A);539 B 403 ( 3.9A);SAM B 402 (-3.7A); ZN B 401 ( 2.3A);SAM B 402 (-4.6A); ZN B 401 ( 2.2A)","0.48A","5wbvB-5cprB:35.5","5wbvB-5cprB:97.80"],["5WBV_B_SAMB402_0","HISTONE-LYSINE N-METHYLTRANSFERASE KMT5B","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",11,"TYR B 203;SER B 205;GLY B 209;ALA B 210;SER B 251;HIS B 273;TYR B 307;PHE B 312;CYH B 319;GLU B 320;CYH B 321","SAM B 402 (-3.7A);SAM B 402 (-2.7A);SAM B 402 (-3.4A);SAM B 402 (-3.9A);SAM B 402 (-3.9A);SAM B 402 (-4.5A);539 B 403 ( 3.9A);SAM B 402 (-3.7A); ZN B 401 ( 2.3A);SAM B 402 (-4.6A); ZN B 401 ( 2.2A)","0.59A","5wbvB-5cprB:35.5","5wbvB-5cprB:97.80"],["5WBV_B_SAMB402_1","HISTONE-LYSINE N-METHYLTRANSFERASE KMT5B","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",3,"HIS B  98;GLU B 206;ASN B 272","SAM B 402 (-3.7A);SAM B 402 (-2.9A);SAM B 402 (-3.1A)","0.22A","5wbvB-5cprB:35.5","5wbvB-5cprB:97.80"],["6A5K_A_SAMA805_0","HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC SUVH6","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",5,"ASN B 272;HIS B 273;TYR B 307;CYH B 319;CYH B 321","SAM B 402 (-3.1A);SAM B 402 (-4.5A);539 B 403 ( 3.9A); ZN B 401 ( 2.3A); ZN B 401 ( 2.2A)","0.42A","6a5kA-5cprB:8.3","6a5kA-5cprB:21.76"],["6A5M_A_SAMA805_0","HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC SUVH6","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",5,"ASN B 272;HIS B 273;TYR B 307;CYH B 319;CYH B 321","SAM B 402 (-3.1A);SAM B 402 (-4.5A);539 B 403 ( 3.9A); ZN B 401 ( 2.3A); ZN B 401 ( 2.2A)","0.38A","6a5mA-5cprB:undetectable","6a5mA-5cprB:21.76"],["6AGO_A_SAMA2301_0","HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",5,"ASN B 272;HIS B 273;TYR B 307;CYH B 319;CYH B 321","SAM B 402 (-3.1A);SAM B 402 (-4.5A);539 B 403 ( 3.9A); ZN B 401 ( 2.3A); ZN B 401 ( 2.2A)","0.87A","6agoA-5cprB:7.8","6agoA-5cprB:26.33"],["6CEN_A_SAMA1301_0","HISTONE-LYSINE N-METHYLTRANSFERASE NSD3","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",5,"ASN B 272;HIS B 273;TYR B 307;CYH B 319;CYH B 321","SAM B 402 (-3.1A);SAM B 402 (-4.5A);539 B 403 ( 3.9A); ZN B 401 ( 2.3A); ZN B 401 ( 2.2A)","0.53A","6cenA-5cprB:7.4","6cenA-5cprB:23.76"],["6INE_A_SAMA2304_0","HISTONE-LYSINE N-METHYLTRANSFERASE ASH1L","5cpr","HISTONE-LYSINE N-METHYLTRANSFERASE SUV420H1","Homo sapiens",5,"ASN B 272;HIS B 273;TYR B 307;CYH B 319;CYH B 321","SAM B 402 (-3.1A);SAM B 402 (-4.5A);539 B 403 ( 3.9A); ZN B 401 ( 2.3A); ZN B 401 ( 2.2A)","0.49A","6ineA-5cprB:7.5","6ineA-5cprB:25.33"]]